Ireland - English - HPRA (Health Products Regulatory Authority)

synthon bv - olanzapine benzoate - tablets - 7.5 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddy's laboratories australia pty ltd - zolpidem tartrate -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

synthon b.v. - tamsulosin hydrochloride 0,4 mg - modified-release capsule, hard - 0,4 mg - tamsulosin hydrochloride 0.4 mg - tamsulosin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

synthon b.v. - tamsulosin hydrochloride 0,4 mg - modified-release capsule, hard - tamsulosin

Singapore - English - HSA (Health Sciences Authority)

bicon singapore pte. ltd. - dental - synthograft is designed for the filling and/or reconstruction of either traumatic or degenerative multi-wall bone defects, the augmentation of the sinus floor, the augmentation of atrophied alveolar ridges, the filling of periodontal or other alveolar bone defects and tooth sockets and osteotomies, and the preservation of the alveolous for the preparation of an implant site.

Israel - English - Ministry of Health

rekah pharmaceutical industry ltd, israel - chloramphenicol - ophtalmic ointment - chloramphenicol 5 % - chloramphenicol - chloramphenicol - for eye infections due to chloramphenicol susceptible microorganisms.

United States - English - NLM (National Library of Medicine)

syntho pharmaceuticals inc. - isoxsuprine hydrochloride (unii: v74teq36co) (isoxsuprine - unii:r15ui3245n) - based on a review of this drug by the national academy of sciences-national research and/or other information, the fda has classified the indications as follows: possibly effective: - for the relief of symptoms associated with cerebrovascular insufficiency. - in peripheral vascular disease of arteriosclerosis obliterans, thromboangitis obliterans (buerger's disease) and raynaud's disease. final classification of the less-than-effective indications requires further investigation. there are no known contraindications to oral use when administered in recommended doses. isoxsuprine hydrochloride, usp should not be given immediately postpartum or in the presence of arterial bleeding.

United States - English - NLM (National Library of Medicine)

syntho pharmaceuticals inc. - isoxsuprine hydrochloride (unii: v74teq36co) (isoxsuprine - unii:r15ui3245n) - based on a review of this drug by the national academy of sciences-national research and/or other information, the fda has classified the indications as follows: possibly effective: - for the relief of symptoms associated with cerebrovascular insufficiency. - in peripheral vascular disease of arteriosclerosis obliterans, thromboangitis obliterans (buerger's disease) and raynaud's disease. final classification of the less-than-effective indications requires further investigation. there are no known contraindications to oral use when administered in recommended doses. isoxsuprine hydrochloride, usp should not be given immediately postpartum or in the presence of arterial bleeding.

United States - English - NLM (National Library of Medicine)

syntho pharmaceuticals, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - pain reliever/fever reducer - temporarily relieves minor aches and pains - temporarily reduces fever

United States - English - NLM (National Library of Medicine)

syntho pharmaceuticals, inc. - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: - runny nose - sneezing - itching of the nose or throat - itchy, watery eyes - nasal congestion - reduces swelling of nasal passages